NanoViricides Inc. (NNVC)

[changes_iv]

Once broad-spectrum FluCide gets FDA review and approval for market, in the event of a need to develop/optimize more for new mutant/strain of Influenza, how long would it take to get a new broad-spectrum FluCide through FDA review? A month? Two months?

6 August 2009 | GENEVA - It takes approximately five to six months for the first supplies of approved vaccine to become available once a new strain of influenza virus with pandemic potential is identified and isolated. These months are needed because the process of producing a new vaccine involves many sequential steps, and each of these steps requires a certain amount of time to complete.
source: http://www.who.int/csr/disease/swineflu/notes/h1n1_vaccine_20090806/en/index.html

"...we are a company...with the ability to rapidly create drugs, and when I say rapidly create drugs I'm talking about weeks instead of years..." ~ Dr. Eugene Seymour, CEO Nanoviricides, Inc

.

"by the way, I'm sure that when you think human trials for drugs you think of hundreds of millions of dollars and years of time, well in this case because the disease only lasts a week, two weeks,...that it is possible to complete human trials in the space of a few short months...four parts to the human trials" ~ Dr. Eugene Seymour, CEO Nanoviricides, Inc.